3 key take-aways from BIO Patient and Health Advocacy Summit

Contributor

Laura Mueller Essential Insights contributor, healthcare writer

Laura Mueller

Essential Insights contributor, healthcare writer

1. Biopharma companies and patient advocacy groups have a responsibility to work together on patients' behalf

2. Drug affordability and accessibility remains a top concern

3. Patient experience data must be a guiding force in drug development